Boston Scientific

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Boston Scientific 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BSX

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. 

CEO
Michael F. Mahoney
CEOMichael F. Mahoney
Employees
59,000
Employees59,000
Headquarters
Marlborough, Massachusetts
HeadquartersMarlborough, Massachusetts
Founded
1979
Founded1979
Employees
59,000
Employees59,000

BSX Key Statistics

Market cap
67.98B
Market cap67.98B
Price-Earnings ratio
18.71
Price-Earnings ratio18.71
Dividend yield
Dividend yield
Average volume
16.87M
Average volume16.87M
High today
$46.32
High today$46.32
Low today
$44.50
Low today$44.50
Open price
$44.60
Open price$44.60
Volume
20.04M
Volume20.04M
52 Week high
$109.50
52 Week high$109.50
52 Week low
$42.20
52 Week low$42.20

Stock Snapshot

As of today, Boston Scientific(BSX) shares are valued at $45.23. The company's market cap stands at 67.98B, with a P/E ratio of 18.71.

On 2026-07-27, Boston Scientific(BSX) stock moved within a range of $44.50 to $46.32. With shares now at $45.23, the stock is trading +1.6% above its intraday low and -2.4% below the session's peak.

Trading volume for Boston Scientific(BSX) stock has reached 20.04M, versus its average volume of 16.87M.

The stock's 52-week range extends from a low of $42.20 to a high of $109.50.

The stock's 52-week range extends from a low of $42.20 to a high of $109.50.

BSX News

Seeking Alpha 57m
Boston Scientific to cut jobs under restructuring plan through 2029

Boston Scientific (BSX) disclosed in a regulatory filing it expects to reduce headcount as part of a global restructuring program aimed at improving cost effici...

Boston Scientific to cut jobs under restructuring plan through 2029
TipRanks 2h
Boston Scientific Launches 2026 Global Restructuring Plan

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...

TipRanks 6h
Boston Scientific’s FARAFLEX AFib Trial Steps Up the Pulsed Field Ablation Race

Boston Scientific (BSX) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confid...

Analyst ratings

87%

of 31 ratings
Buy
87.1%
Hold
12.9%
Sell
0%

More BSX News

TipRanks 10h
Boston Scientific price target lowered to $85 from $90 at Oppenheimer

Oppenheimer lowered the firm’s price target on Boston Scientific (BSX) to $85 from $90 and keeps an Outperform rating on the shares ahead of quarterly results....

Simply Wall St 2d
What Boston Scientific's Stronger-Than-Expected Segment Earnings Mean For Shareholders

Earlier this week, Boston Scientific reported quarterly earnings of US$0.83 per share and revenues of US$5.39 billion, both increasing from the prior year, with...

What Boston Scientific's Stronger-Than-Expected Segment Earnings Mean For Shareholders
Simply Wall St 3d
Boston Scientific Faces Recall Scrutiny, Is The Stock 56% Undervalued?

Boston Scientific (BSX) is under renewed investor scrutiny after a series of voluntary Class II recalls for its CRE and CRE Pro Wireguided gastrointestinal devi...

Boston Scientific Faces Recall Scrutiny, Is The Stock 56% Undervalued?
Nasdaq 4d
September 4th Options Now Available For Boston Scientific

Investors in Boston Scientific Corp. (Symbol: BSX) saw new options become available today, for the September 4th expiration. At Stock Options Channel , our Yiel...

September 4th Options Now Available For Boston Scientific
Simply Wall St 4d
Boston Scientific Starts Global Faraflex Trial With First Atrial Fibrillation Patient

Boston Scientific (NYSE:BSX) has enrolled the first patient in the FARADIGM global IDE trial for its Faraflex pulsed field ablation catheter. The FARADIGM stud...

Boston Scientific Starts Global Faraflex Trial With First Atrial Fibrillation Patient
Simply Wall St 6d
Boston Scientific Stock Looks Below Fair Value Even As Returns Stay Weak

Boston Scientific stock is coming off a difficult stretch, with the share price down 58.1% over the past year, yet the broader valuation checks still lean towar...

Boston Scientific Stock Looks Below Fair Value Even As Returns Stay Weak

People also own

Based on the portfolios of people who own BSX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.